Qube Research & Technologies (QRT)
BIO icon

Qube Research & Technologies (QRT)’s Bio-Rad Laboratories Class A BIO Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$6.69M Buy
+17,721
New +$6.19M 0.01% 1669
2024
Q2 		– Sell
-72,770
Closed -$25.2M – 3832
2024
Q1 		$25.2M Sell
72,770
-97,148
-57% -$31.9M 0.04% 488
2023
Q4 		$54.9M Buy
169,918
+168,970
+17,824% +$53M 0.11% 240
2023
Q3 		$340K Buy
+948
New +$366K ﹤0.01% 2190
2023
Q1 		– Sell
-8,532
Closed -$3.59M – 2551
2022
Q4 		$3.59M Sell
8,532
-7,407
-46% -$2.99M 0.02% 754
2022
Q3 		$6.65M Buy
15,939
+5,058
+46% +$2.52M 0.04% 528
2022
Q2 		$5.39M Sell
10,881
-17,640
-62% -$9.19M 0.04% 480
2022
Q1 		$16.1M Sell
28,521
-1,283
-4% -$773K 0.14% 195
2021
Q4 		$22.5M Buy
29,804
+6,194
+26% +$4.64M 0.17% 124
2021
Q3 		$17.6M Buy
23,610
+23,121
+4,728% +$17.3M 0.22% 100
2021
Q2 		$315K Sell
489
-10,915
-96% -$6.64M ﹤0.01% 1549
2021
Q1 		$6.51M Buy
+11,404
New +$6.75M 0.1% 245
2020
Q4 		– Sell
-9,585
Closed -$4.94M – 1816
2020
Q3 		$4.94M Sell
9,585
-18,473
-66% -$9.36M 0.07% 358
2020
Q2 		$12.7M Buy
28,058
+27,445
+4,477% +$12.1M 0.19% 122
2020
Q1 		$215K Buy
613
+35
+6% +$12.9K 0.01% 847
2019
Q4 		$214K Buy
+578
New +$204K 0.01% 1362
2019
Q3 		– Sell
-738
Closed -$231K – 261
2019
Q2 		$231K Buy
+738
New +$221K 0.06% 323
2018
Q4 		– Sell
-763
Closed -$239K – 360
2018
Q3 		$239K Buy
763
+624
+449% +$194K 0.03% 440
2018
Q2 		$40K Buy
+139
New +$38.4K 0.03% 583

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $63.7B AUM 20.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Ariel Investments
Ariel Investments Chicago, Illinois $9.6B AUM 22.21% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $25.4B AUM 35.48% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $148B AUM 31.56% 1-Year Est. Return

Qube Research & Technologies (QRT)'s BIO Position: Q3 2026 in Review

Qube Research & Technologies (QRT) opened a new position in Bio-Rad Laboratories Class A (BIO) in Q3 2026: 17,721 shares worth $6.69M. The stake represents 0.01% of the portfolio and ranks #1669 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in BIO as recently as Q1 2024.

Qube Research & Technologies (QRT) first reported a position in BIO in Q2 2018 and has held it in 19 quarters since. The position peaked at $54.9M in Q4 2023. 327 funds tracked by Wall St. Rank hold BIO as of Q3 2026.

  • Qube Research & Technologies (QRT) held 17,721 shares of Bio-Rad Laboratories Class A worth $6.69M as of Q3 2026.
  • Bio-Rad Laboratories Class A was a new Qube Research & Technologies (QRT) position in Q3 2026.
  • Bio-Rad Laboratories Class A made up 0.01% of Qube Research & Technologies (QRT)'s portfolio in Q3 2026, its #1669 holding.
  • Qube Research & Technologies (QRT) first reported a position in Bio-Rad Laboratories Class A in Q2 2018 and has held it in 19 quarters since.
  • Qube Research & Technologies (QRT)'s Bio-Rad Laboratories Class A position peaked at $54.9M in Q4 2023.
  • 327 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2026, filed 13 Nov 2026.